Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver
Asieh Mansour

Assistant Professor of Nutritional Sciences

Department Internal Medicine

School of Medicine

Shariati Hospital

Tehran University of Medical Sciences

All Documents
1. Effect of Nano-Curcumin Supplementation on Liver Fibrosis in Patients With Nafld-Associated Fibrosis: A Double-Blind Randomized Controlled Trial, Scientific Reports (2025)
2. Risk Factors for Cognitive Impairment in Type 2 Diabetes Patients, Journal of Diabetes and Metabolic Disorders (2025)
3. The Association Between Dietary Consumption of Amino Acids and the Risk of Non-Alcoholic Fatty Liver Disease: A Case-Control Study, Nutrition and Metabolism (2025)
4. The Effectiveness and Safety of Nanocurcumin Supplementation for Diabetic Peripheral Neuropathy in Patients With Type 2 Diabetes: A Randomized Double-Blind Clinical Trial, Nutrition Journal (2025)
5. The Efficacy and Safety of Berberine in Combination With Cinnamon Supplementation in Patients With Type 2 Diabetes: A Randomized Clinical Trial, European Journal of Nutrition (2025)
6. Dietary Amino Acids Intake and All-Cause and Cause-Specific Mortality: Results From the Golestan Cohort Study, Nutrition Journal (2024)
7. Hyperandrogenism and Anthropometric Parameters in Women With Polycystic Ovary Syndrome, BMC Endocrine Disorders (2024)
8. Regional Fat Distribution and Hepatic Fibrosis and Steatosis Severity in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes, Obesity Science and Practice (2024)
9. The Effect of Conjugated Linoleic Acid Supplementation in Comparison With Omega-6 and Omega-9 on Lipid Profile: A Graded, Dose–Response Systematic Review and Meta-Analysis of Randomized Controlled Trials, Frontiers in Nutrition (2024)
10. Association Between Dietary Glycemic Index and Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus, Frontiers in Endocrinology (2023)
11. Association Between Dietary Glycemic Index and Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus, Frontiers in Endocrinology (2023)
12. Association of Dietary Phytochemical Index and Anthropometric Risk Factors With Non-Alcoholic Fatty Liver Disease in People With Diabetes, Iranian Journal of Nutrition Sciences and Food Technology (2023)
13. Factors Related to Hypermetabolism in Individuals With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease, Scientific Reports (2023)
14. Prevalence of Thyroid Dysfunction Among Iranian Older Adults: A Cross-Sectional Study, Scientific Reports (2023)
15. Risk Factors for Insulin Resistance Related to Polycystic Ovarian Syndrome in Iranian Population, Scientific Reports (2023)
16. Serum Vitamin D Status and Cognitive Function in Iranian Older Adults: Evidence From the Birjand Longitudinal Aging Study, Journal of Nutrition (2023)
17. The Association of Dietary Inflammatory Index (Dii) and Central Obesity With Non-Alcoholic Fatty Liver Disease (Nafld) in People With Diabetes (T2dm), Heliyon (2023)
18. Dietary Total Antioxidant Capacity Is Inversely Associated With the Odds of Non-Alcoholic Fatty Liver Disease in People With Type-2 Diabetes, Frontiers in Nutrition (2022)
19. Effect of Resveratrol Administration on Ovarian Morphology, Determined by Transvaginal Ultrasound for the Women With Polycystic Ovary Syndrome (Pcos), British Journal of Nutrition (2022)
20. Ovarian Volume, Not Follicle Count, Is Independently Associated With Androgens in Patients With Polycystic Ovary Syndrome, BMC Endocrine Disorders (2022)
21. The Effects of Antioxidants on Knee Osteoarthritis: A Systematic Review and Meta-Analysis, Frontiers in Nutrition (2022)
22. Effect of Glutamine Supplementation on Cardiometabolic Risk Factors and Inflammatory Markers: A Systematic Review and Meta-Analysis, BMC Cardiovascular Disorders (2021)
23. Effect of Resveratrol on Menstrual Cyclicity, Hyperandrogenism and Metabolic Profile in Women With Pcos, Clinical Nutrition (2021)
24. Effects of Supplementation With Main Coffee Components Including Caffeine And/Or Chlorogenic Acid on Hepatic, Metabolic, and Inflammatory Indices in Patients With Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial, Nutrition Journal (2021)
25. Clinical Characteristics and Outcomes of Diabetics Hospitalized for Covid-19 Infection: A Single-Centered, Retrospective, Observational Study, EXCLI Journal (2020)
26. Postprandial Glycemia and Insulin Secretion Following Glutamine Administration: A Randomized Controlled Trial, International Journal for Vitamin and Nutrition Research (2020)
27. Short Term Effects of Coffee Components Consumption on Gut Microbiota in Patients With Non-Alcoholic Fatty Liver and Diabetes: A Pilot Randomized Placebo-Controlled, Clinical Trial, EXCLI Journal (2020)
28. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial, Frontiers in Endocrinology (2020)
29. Vitamin D Supplementation in Covid-19: A Friend or Foe?, EXCLI Journal (2020)
30. Curcumin and Inflammation in Non-Alcoholic Fatty Liver Disease: A Randomized, Placebo Controlled Clinical Trial, BMC Gastroenterology (2019)
31. Risk Factors for Non-Alcoholic Fatty Liver Disease-Associated Hepatic Fibrosis in Type 2 Diabetes Patients, Acta Diabetologica (2019)
32. The Effects of Curcumin Supplementation on Liver Enzymes, Lipid Profile, Glucose Homeostasis, and Hepatic Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease, European Journal of Clinical Nutrition (2019)
33. Amino Acids Levels Related to Glutamine Supplementation for Type 2 Diabetes Patients, Biomedical Research (India) (2018)
34. Association Between Low Bone Mass and the Serum Rankl and Opg in Patients With Nephrolithiasis, BMC Nephrology (2018)
35. Nutrients As Novel Therapeutic Approaches for Metabolic Disturbances in Polycystic Ovary Syndrome, EXCLI Journal (2016)
36. Effect of Glutamine Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes, Nutrition (2015)